Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NVTA

Invitae (NVTA)

Invitae Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NVTA
DateTimeSourceHeadlineSymbolCompany
07/19/20226:47PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:NVTAInvitae Corporation
07/18/20224:13PMPR Newswire (US)Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow and Realize Full Potential of Industry-Leading Genetics Testing PlatformNYSE:NVTAInvitae Corporation
07/18/20224:05PMPR Newswire (US)Invitae Announces Leadership TransitionNYSE:NVTAInvitae Corporation
06/10/20224:39PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
05/27/20227:00AMPR Newswire (US)Invitae to Present at Upcoming Investor ConferencesNYSE:NVTAInvitae Corporation
05/26/20225:05PMPR Newswire (US)New Research Demonstrates Genetic Information Can Transform Cancer Care, Guidelines Remain a Barrier to Patient AccessNYSE:NVTAInvitae Corporation
05/19/20225:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
05/19/20225:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
05/19/20225:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
05/19/20225:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
05/19/20226:30AMPR Newswire (US)Invitae Launches Expanded Pharmacogenomics Panel and Specialized Mental Health PanelNYSE:NVTAInvitae Corporation
05/03/20225:13PMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:NVTAInvitae Corporation
05/03/20224:05PMPR Newswire (US)Invitae Reports $123.7 Million in Revenue in First Quarter of 2022 and Extends Cash RunwayNYSE:NVTAInvitae Corporation
05/03/20226:00AMPR Newswire (US)Allelica Collaborates with Invitae to Build Ancestry-Informed Polygenic Risk Score for Breast CancerNYSE:NVTAInvitae Corporation
05/02/20224:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
04/21/20224:33PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:NVTAInvitae Corporation
04/21/20224:33PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:NVTAInvitae Corporation
04/20/20226:59AMPR Newswire (US)Invitae to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022NYSE:NVTAInvitae Corporation
04/18/20228:39AMTipRanksRaymond James Thinks Invitaeā€™s Stock is Going to RecoverNYSE:NVTAInvitae Corporation
04/12/20224:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
04/12/20224:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
04/12/20224:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
04/12/20224:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
04/12/20224:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
04/06/202210:25PMTipRanksAnalysts Are Bullish on These Healthcare Stocks: Invitae (NVTA), HCA Healthcare (HCA)NYSE:NVTAInvitae Corporation
04/04/20224:17PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:NVTAInvitae Corporation
04/04/20226:30AMPR Newswire (US)Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental DisordersNYSE:NVTAInvitae Corporation
03/29/20226:30AMPR Newswire (US)Introducing Invitae Digital Health--A Personalized Health Management Platform That Leverages Genomic Insights to Inform Health Decisions for Patients and CliniciansNYSE:NVTAInvitae Corporation
03/21/20224:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
03/17/20226:30AMPR Newswire (US)Invitae Launches Full Access to its Liquid-Based Personalized Cancer Monitoring Platform to Help Detect Disease EarlierNYSE:NVTAInvitae Corporation
 Showing the most relevant articles for your search:NYSE:NVTA

Your Recent History

Delayed Upgrade Clock